Thyroid function tests in acute viral hepatitis: relative reduction in serum thyroxine levels due to T4-TBG binding inhibitors in patients with severe liver cell necrosis

M. C. Pagliacci, G. Pelicci, D. Francisco, C. Giammartino, L. Fedeli, G. Stagni, I. Nicoletti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Thyroid function tests were evaluated in 34 patients with acute viral hepatitis (AVH) and in 38 healthy controls (C). As expected, AVH patients displayed a significant increase in T4, rT3 and TBG serum levels with respect to C, while FT4 and TSH concentrations were similar. A positive correlation between TBG and T4 was evident in C, but not in AVH. In this group there was, instead, an inverse correlation between the sum of serum levels of GOT + GPT and T4 concentrations. When AVH patients were divided in “high necrosis” (HN, serum GOT + GPT > 2000 Ul/I) and “low necrosis” (LN, serum GOT + GPT <2000 Ul/ml) groups, we found a significant reduction in both T4 and T3 serum concentrations in HN with respect to LN, despite similar levels of TBG, albumin, FT4 and TSH. The hypothesis that thyroid-hormone binding inhibitors (THBI), released during severe liver cell injury, accounted for an impaired serum binding capacity in HN-AVH, was confirmed by the significant increase in FT4/T4 ratio and by the demonstration of THBI activity in pooled sera of these patients, with respect to LN subgroup. Our present finding may clarify the unexplained observation of reduced T4 levels in patients with fulminant hepatitis and the ominous prognostic significance of a “low T4 syndrome” in subjects with severe liver disease and/or other systemic illnesses.

Original languageEnglish
Pages (from-to)149-153
Number of pages5
JournalJournal of Endocrinological Investigation
Volume12
Issue number3
DOIs
Publication statusPublished - 1989

Fingerprint

Thyroid Function Tests
Thyroxine
Hepatitis
Necrosis
Liver
Serum
Thyroid Hormones
Liver Diseases
Albumins
Observation
Wounds and Injuries

Keywords

  • Acute hepatitis
  • TBG
  • thyroid hormone-TBG binding inhibitors
  • thyroid hormones

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Thyroid function tests in acute viral hepatitis : relative reduction in serum thyroxine levels due to T4-TBG binding inhibitors in patients with severe liver cell necrosis. / Pagliacci, M. C.; Pelicci, G.; Francisco, D.; Giammartino, C.; Fedeli, L.; Stagni, G.; Nicoletti, I.

In: Journal of Endocrinological Investigation, Vol. 12, No. 3, 1989, p. 149-153.

Research output: Contribution to journalArticle

@article{52d6c24685904fe298825d56aa32e167,
title = "Thyroid function tests in acute viral hepatitis: relative reduction in serum thyroxine levels due to T4-TBG binding inhibitors in patients with severe liver cell necrosis",
abstract = "Thyroid function tests were evaluated in 34 patients with acute viral hepatitis (AVH) and in 38 healthy controls (C). As expected, AVH patients displayed a significant increase in T4, rT3 and TBG serum levels with respect to C, while FT4 and TSH concentrations were similar. A positive correlation between TBG and T4 was evident in C, but not in AVH. In this group there was, instead, an inverse correlation between the sum of serum levels of GOT + GPT and T4 concentrations. When AVH patients were divided in “high necrosis” (HN, serum GOT + GPT > 2000 Ul/I) and “low necrosis” (LN, serum GOT + GPT <2000 Ul/ml) groups, we found a significant reduction in both T4 and T3 serum concentrations in HN with respect to LN, despite similar levels of TBG, albumin, FT4 and TSH. The hypothesis that thyroid-hormone binding inhibitors (THBI), released during severe liver cell injury, accounted for an impaired serum binding capacity in HN-AVH, was confirmed by the significant increase in FT4/T4 ratio and by the demonstration of THBI activity in pooled sera of these patients, with respect to LN subgroup. Our present finding may clarify the unexplained observation of reduced T4 levels in patients with fulminant hepatitis and the ominous prognostic significance of a “low T4 syndrome” in subjects with severe liver disease and/or other systemic illnesses.",
keywords = "Acute hepatitis, TBG, thyroid hormone-TBG binding inhibitors, thyroid hormones",
author = "Pagliacci, {M. C.} and G. Pelicci and D. Francisco and C. Giammartino and L. Fedeli and G. Stagni and I. Nicoletti",
year = "1989",
doi = "10.1007/BF03349947",
language = "English",
volume = "12",
pages = "149--153",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "3",

}

TY - JOUR

T1 - Thyroid function tests in acute viral hepatitis

T2 - relative reduction in serum thyroxine levels due to T4-TBG binding inhibitors in patients with severe liver cell necrosis

AU - Pagliacci, M. C.

AU - Pelicci, G.

AU - Francisco, D.

AU - Giammartino, C.

AU - Fedeli, L.

AU - Stagni, G.

AU - Nicoletti, I.

PY - 1989

Y1 - 1989

N2 - Thyroid function tests were evaluated in 34 patients with acute viral hepatitis (AVH) and in 38 healthy controls (C). As expected, AVH patients displayed a significant increase in T4, rT3 and TBG serum levels with respect to C, while FT4 and TSH concentrations were similar. A positive correlation between TBG and T4 was evident in C, but not in AVH. In this group there was, instead, an inverse correlation between the sum of serum levels of GOT + GPT and T4 concentrations. When AVH patients were divided in “high necrosis” (HN, serum GOT + GPT > 2000 Ul/I) and “low necrosis” (LN, serum GOT + GPT <2000 Ul/ml) groups, we found a significant reduction in both T4 and T3 serum concentrations in HN with respect to LN, despite similar levels of TBG, albumin, FT4 and TSH. The hypothesis that thyroid-hormone binding inhibitors (THBI), released during severe liver cell injury, accounted for an impaired serum binding capacity in HN-AVH, was confirmed by the significant increase in FT4/T4 ratio and by the demonstration of THBI activity in pooled sera of these patients, with respect to LN subgroup. Our present finding may clarify the unexplained observation of reduced T4 levels in patients with fulminant hepatitis and the ominous prognostic significance of a “low T4 syndrome” in subjects with severe liver disease and/or other systemic illnesses.

AB - Thyroid function tests were evaluated in 34 patients with acute viral hepatitis (AVH) and in 38 healthy controls (C). As expected, AVH patients displayed a significant increase in T4, rT3 and TBG serum levels with respect to C, while FT4 and TSH concentrations were similar. A positive correlation between TBG and T4 was evident in C, but not in AVH. In this group there was, instead, an inverse correlation between the sum of serum levels of GOT + GPT and T4 concentrations. When AVH patients were divided in “high necrosis” (HN, serum GOT + GPT > 2000 Ul/I) and “low necrosis” (LN, serum GOT + GPT <2000 Ul/ml) groups, we found a significant reduction in both T4 and T3 serum concentrations in HN with respect to LN, despite similar levels of TBG, albumin, FT4 and TSH. The hypothesis that thyroid-hormone binding inhibitors (THBI), released during severe liver cell injury, accounted for an impaired serum binding capacity in HN-AVH, was confirmed by the significant increase in FT4/T4 ratio and by the demonstration of THBI activity in pooled sera of these patients, with respect to LN subgroup. Our present finding may clarify the unexplained observation of reduced T4 levels in patients with fulminant hepatitis and the ominous prognostic significance of a “low T4 syndrome” in subjects with severe liver disease and/or other systemic illnesses.

KW - Acute hepatitis

KW - TBG

KW - thyroid hormone-TBG binding inhibitors

KW - thyroid hormones

UR - http://www.scopus.com/inward/record.url?scp=0024517350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024517350&partnerID=8YFLogxK

U2 - 10.1007/BF03349947

DO - 10.1007/BF03349947

M3 - Article

C2 - 2498420

AN - SCOPUS:0024517350

VL - 12

SP - 149

EP - 153

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 3

ER -